Our aim is to bring down the dependence on Thiabendazole in the total portfolio to about 50 per cent in the next three years
Having started operations in 1988, Hikal Chemicals, the only producer of Thiabendazole in the world, has come a long way in becoming a Rs 1 billion company. Engaged in the business of contract manufacture of pharmaceuticals, agrochemicals and intermediates, the company has taken rapid steps towards expanding business.
Following the acquisition of Novartis
